Jiri Bartek

2.6k total citations
16 papers, 2.1k citations indexed

About

Jiri Bartek is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Jiri Bartek has authored 16 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 4 papers in Cell Biology. Recurrent topics in Jiri Bartek's work include Cancer-related Molecular Pathways (12 papers), Ubiquitin and proteasome pathways (4 papers) and Microtubule and mitosis dynamics (4 papers). Jiri Bartek is often cited by papers focused on Cancer-related Molecular Pathways (12 papers), Ubiquitin and proteasome pathways (4 papers) and Microtubule and mitosis dynamics (4 papers). Jiri Bartek collaborates with scholars based in Denmark, Germany and Sweden. Jiri Bartek's co-authors include Jiřina Bártková, Mike Strauss, Erich A. Nigg, Andrew M. Fry, Patrick Meraldi, Kristian Helin, Mikkel Rohde, Jiří Lukáš, Birgit Otzen Petersen and Karin Holm and has published in prestigious journals such as Nature Medicine, Nature Cell Biology and Molecular and Cellular Biology.

In The Last Decade

Jiri Bartek

15 papers receiving 2.1k citations

Peers

Jiri Bartek

ONCOL

GENET

Steve Coats United States

David K. Strom United States

Vera Fantl United Kingdom

Qunyan Yu United States

Harold I. Saavedra United States

Marc Webster Canada

Pumin Zhang United States

J H Pierce United States

Douglas Woods United States

Greg H. Enders United States

Steve Coats United States

Jiri Bartek

1.6k ×1.1

1.4k ×1.0

ONCOL

392 ×0.6

119 ×0.5

GENET

300 ×1.2

Citations per year, relative to Jiri Bartek Jiri Bartek (= 1×) peers Steve Coats

Countries citing papers authored by Jiri Bartek

Since Specialization

Citations

This map shows the geographic impact of Jiri Bartek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiri Bartek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiri Bartek more than expected).

Fields of papers citing papers by Jiri Bartek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiri Bartek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiri Bartek. The network helps show where Jiri Bartek may publish in the future.

Co-authorship network of co-authors of Jiri Bartek

This figure shows the co-authorship network connecting the top 25 collaborators of Jiri Bartek. A scholar is included among the top collaborators of Jiri Bartek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiri Bartek. Jiri Bartek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Carstam, Louise, Ida Häggström, Francesco Latini, et al.. (2025). Survival prediction with radiomics for patients with IDH mutated lower-grade glioma. Journal of Neuro-Oncology. 173(3). 505–514.

Kinhult, Sara, Tora S. Solheim, Henriette Magelssen, et al.. (2023). Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma. JAMA Network Open. 6(3). e234149–e234149. 31 indexed citations

Stejskal, David, et al.. (2001). [Initial experience with use of cationic propyl gallate as an inducer of thrombocyte aggregation in evaluation of anti-aggregation therapy].. PubMed. 47(11). 747–52. 1 indexed citations

Bártková, Jiřina, Minna Thullberg, Ewa Rajpert-De Meyts, Niels E. Skakkebæk, & Jiri Bartek. (2000). Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene. 19(36). 4146–4150. 44 indexed citations

Bártková, Jiřina, Minna Thullberg, Ewa Rajpert‐De Meyts, Niels E. Skakkebæk, & Jiri Bartek. (2000). Cell cycle regulators in testicular cancer: Loss of p18INK4C marks progression from carcinomain situ to invasive germ cell tumours. International Journal of Cancer. 85(3). 370–375. 54 indexed citations

Santoni‐Rugiu, Eric, et al.. (2000). Involvement of Myc Activity in a G1/S-Promoting Mechanism Parallel to the pRb/E2F Pathway. Molecular and Cellular Biology. 20(10). 3497–3509. 15 indexed citations

Meraldi, Patrick, et al.. (1999). Centrosome duplication in mammalian somatic cells requires E2F and Cdk2–Cyclin A. Nature Cell Biology. 1(2). 88–93. 398 indexed citations

Welcker, Markus, Jiří Lukáš, M. Strauß, & Jiri Bartek. (1998). p21WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cells.. PubMed. 58(22). 5053–6. 28 indexed citations

Sandig, Volker, et al.. (1997). Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nature Medicine. 3(3). 313–319. 192 indexed citations

10.

Schulze, Almut, Werner Zwerschke, Beate Vogt, et al.. (1997). p27 ^KIP1 Blocks Cyclin E-Dependent Transactivation of Cyclin A Gene Expression. Molecular and Cellular Biology. 17(1). 407–415. 106 indexed citations

11.

Bartek, Jiri, et al.. (1996). The retinoblastoma protein pathway and the restriction point. Current Opinion in Cell Biology. 8(6). 805–814. 322 indexed citations

12.

Petersen, Birgit Otzen, et al.. (1996). Deregulated Expression of E2F Family Members Induces S-Phase Entry and Overcomes p16 ^INK4A -Mediated Growth Suppression. Molecular and Cellular Biology. 16(3). 1047–1057. 255 indexed citations

13.

Ott, Michaela, German Ott, Jiri Bartek, et al.. (1996). bcl‐1 REARRANGEMENT AND CYCLIN D1 PROTEIN EXPRESSION IN MANTLE CELL LYMPHOMA. The Journal of Pathology. 179(3). 238–242. 4 indexed citations

14.

Strauss, Mike, et al.. (1995). Unrestricted cell cycling and cancer. Nature Medicine. 1(12). 1245–1246. 139 indexed citations

15.

Bártková, Jiřina, et al.. (1995). Cyclin D1 Is Dispensable for G ₁ Control in Retinoblastoma Gene-Deficient Cells Independently of cdk4 Activity. Molecular and Cellular Biology. 15(5). 2600–2611. 316 indexed citations

16.

Lukáš, Jiří, Michele Pagano, Z Stasková, Giulio Draetta, & Jiri Bartek. (1994). Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.. PubMed. 9(3). 707–18. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact